vimarsana.com
Home
Live Updates
Melyssa Weible - Breaking News
Pages:
12
13
14
15
16
17
18
Page 11 - Melyssa Weible News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Cingulate to Present at Aegis Virtual Conference
Cingulate to Present at Aegis Virtual Conference - read this article along with other careers information, tips and advice on BioSpace
United states
Kansas city
Shanej schaffer
Thomas dalton
Wilkinson brimmer katcher
Melyssa weible
Andy brimmer amy feng
Joele frank
Elixir health public relations
Cingulate inc
Aegis capital corp
Precision timed release
Chief executive officer
Aegis capital
Virtual conference
Aegis virtual conference
Cingulate Appoints Curt Medeiros and Gregg Givens to Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
United states
Kansas city
Curt medeiros
Shanej schaffer
Thomas dalton
Wilkinson brimmer katcher
Melyssa weible
Joele frank
Andy brimmer amy feng
Massachusetts institute of technology
Cingulate inc
Systems inc
Unitedhealth group
Exchange commission
Harvard business school
University of missouri
Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights
Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights - read this article along with other careers information, tips and advice on BioSpace
United states
United kingdom
Scottl zeller
Michaelp watson
Adrian adams
Christina tartaglia
Kimberlyd nordstrom
Melyssa weible
Cambridge university
Impel neuropharma inc
Company guidance
Drug administration
Exchange commission
Cambridge university press
Elixir health public relations
Dihydroergotamine mesylate
Cingulate Inc Announces Pricing of $25 0 Million Initial Public Offering
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
New york
United states
Kansas city
Thomas dalton
Wilkinson brimmer katcher
Melyssa weible
Joele frank
Exchange commission
Laidlaw company united kingdom ltd
Elixir health public relations
Cingulate inc
Syndicate department
Aegis capital corp
Precision timed release
Nasdaq capital market
United kingdom
Cingulate Inc Announces Pricing of $25 0 Million Initial
KANSAS CITY, Kan., Dec. 07, 2021 (GLOBE NEWSWIRE) Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing.
New york
United states
Kansas city
Thomas dalton
Wilkinson brimmer katcher
Melyssa weible
Joele frank
Exchange commission
Laidlaw company united kingdom ltd
Elixir health public relations
Cingulate inc
Syndicate department
Aegis capital corp
Precision timed release
Nasdaq capital market
United kingdom
vimarsana © 2020. All Rights Reserved.